Cargando…
Breast cancer care compared with clinical Guidelines: an observational study in France
BACKGROUND: Great variability in breast cancer (BC) treatment practices according to patient, tumour or organisation of care characteristics has been reported but the relation between these factors is not well known. In two French regions, we measured compliance with Clinical Practice Guidelines for...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3037311/ https://www.ncbi.nlm.nih.gov/pubmed/21251274 http://dx.doi.org/10.1186/1471-2458-11-45 |
_version_ | 1782197970004869120 |
---|---|
author | Lebeau, Marie Mathoulin-Pélissier, Simone Bellera, Carine Tunon-de-Lara, Christine Daban, Alain Lipinski, Francis Jaubert, Dominique Ingrand, Pierre Migeot, Virginie |
author_facet | Lebeau, Marie Mathoulin-Pélissier, Simone Bellera, Carine Tunon-de-Lara, Christine Daban, Alain Lipinski, Francis Jaubert, Dominique Ingrand, Pierre Migeot, Virginie |
author_sort | Lebeau, Marie |
collection | PubMed |
description | BACKGROUND: Great variability in breast cancer (BC) treatment practices according to patient, tumour or organisation of care characteristics has been reported but the relation between these factors is not well known. In two French regions, we measured compliance with Clinical Practice Guidelines for non-metastatic BC care management and identified factors associated with non-compliance at clinical and organisational levels. METHODS: Eligible patients had invasive unilateral BC without distant metastases and at least two contacts with one of the two regional healthcare systems (2003-2004) in the first year after diagnosis. Medical data were collected from patient medical records in all public and private hospitals (99 hospitals). The care process was defined by 20 criteria: clinical decisions for treatment and therapeutic procedures. Each criterion was classified according to level of compliance ("Compliant", "Justifiable" and "Not Compliant") and factors of non-compliance were identified (mixed effect logistic regression). RESULTS: 926 women were included. Non-compliance with clinical decisions for treatment was associated with older patient age (OR 2.1; 95%CI: 1.3-3.6) and region (OR 3.0; 95%CI: 1.2-7.4). Non-compliance with clinical decisions for radiotherapy was associated with lymph node involvement or the presence of peritumoural vascular invasion (OR 1.5; 95%CI: 1.01-2.3) and non-compliance with overall treatment (clinical decisions for treatment + therapeutic procedures) was associated with the presence of positive lymph nodes (OR 2.0; 95%CI: 1.2-3.3), grade III versus grade I (OR 2.9; 95%CI: 1.4-6.2), and one region of care versus another (OR 3.5; 95%CI: 1.7-7.1). Finally, heterogeneity of compliance in overall treatment sequence was identified between local cancer units (p < 0.05). CONCLUSION: This study provides interesting insights into factors of non-compliance in non-metastatic BC management and could lead to quality care improvements. |
format | Text |
id | pubmed-3037311 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-30373112011-02-11 Breast cancer care compared with clinical Guidelines: an observational study in France Lebeau, Marie Mathoulin-Pélissier, Simone Bellera, Carine Tunon-de-Lara, Christine Daban, Alain Lipinski, Francis Jaubert, Dominique Ingrand, Pierre Migeot, Virginie BMC Public Health Research Article BACKGROUND: Great variability in breast cancer (BC) treatment practices according to patient, tumour or organisation of care characteristics has been reported but the relation between these factors is not well known. In two French regions, we measured compliance with Clinical Practice Guidelines for non-metastatic BC care management and identified factors associated with non-compliance at clinical and organisational levels. METHODS: Eligible patients had invasive unilateral BC without distant metastases and at least two contacts with one of the two regional healthcare systems (2003-2004) in the first year after diagnosis. Medical data were collected from patient medical records in all public and private hospitals (99 hospitals). The care process was defined by 20 criteria: clinical decisions for treatment and therapeutic procedures. Each criterion was classified according to level of compliance ("Compliant", "Justifiable" and "Not Compliant") and factors of non-compliance were identified (mixed effect logistic regression). RESULTS: 926 women were included. Non-compliance with clinical decisions for treatment was associated with older patient age (OR 2.1; 95%CI: 1.3-3.6) and region (OR 3.0; 95%CI: 1.2-7.4). Non-compliance with clinical decisions for radiotherapy was associated with lymph node involvement or the presence of peritumoural vascular invasion (OR 1.5; 95%CI: 1.01-2.3) and non-compliance with overall treatment (clinical decisions for treatment + therapeutic procedures) was associated with the presence of positive lymph nodes (OR 2.0; 95%CI: 1.2-3.3), grade III versus grade I (OR 2.9; 95%CI: 1.4-6.2), and one region of care versus another (OR 3.5; 95%CI: 1.7-7.1). Finally, heterogeneity of compliance in overall treatment sequence was identified between local cancer units (p < 0.05). CONCLUSION: This study provides interesting insights into factors of non-compliance in non-metastatic BC management and could lead to quality care improvements. BioMed Central 2011-01-20 /pmc/articles/PMC3037311/ /pubmed/21251274 http://dx.doi.org/10.1186/1471-2458-11-45 Text en Copyright ©2011 Lebeau et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Lebeau, Marie Mathoulin-Pélissier, Simone Bellera, Carine Tunon-de-Lara, Christine Daban, Alain Lipinski, Francis Jaubert, Dominique Ingrand, Pierre Migeot, Virginie Breast cancer care compared with clinical Guidelines: an observational study in France |
title | Breast cancer care compared with clinical Guidelines: an observational study in France |
title_full | Breast cancer care compared with clinical Guidelines: an observational study in France |
title_fullStr | Breast cancer care compared with clinical Guidelines: an observational study in France |
title_full_unstemmed | Breast cancer care compared with clinical Guidelines: an observational study in France |
title_short | Breast cancer care compared with clinical Guidelines: an observational study in France |
title_sort | breast cancer care compared with clinical guidelines: an observational study in france |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3037311/ https://www.ncbi.nlm.nih.gov/pubmed/21251274 http://dx.doi.org/10.1186/1471-2458-11-45 |
work_keys_str_mv | AT lebeaumarie breastcancercarecomparedwithclinicalguidelinesanobservationalstudyinfrance AT mathoulinpelissiersimone breastcancercarecomparedwithclinicalguidelinesanobservationalstudyinfrance AT belleracarine breastcancercarecomparedwithclinicalguidelinesanobservationalstudyinfrance AT tunondelarachristine breastcancercarecomparedwithclinicalguidelinesanobservationalstudyinfrance AT dabanalain breastcancercarecomparedwithclinicalguidelinesanobservationalstudyinfrance AT lipinskifrancis breastcancercarecomparedwithclinicalguidelinesanobservationalstudyinfrance AT jaubertdominique breastcancercarecomparedwithclinicalguidelinesanobservationalstudyinfrance AT ingrandpierre breastcancercarecomparedwithclinicalguidelinesanobservationalstudyinfrance AT migeotvirginie breastcancercarecomparedwithclinicalguidelinesanobservationalstudyinfrance |